3D Cardiac Mapping System Market Report 2024

The 3D cardiac mapping system market size has grown strongly in recent years. It will grow from $1.57 billion in 2023 to $1.73 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth during the historic period can be attributed to the high prevalence of atrial fibrillation, increasing rates of obesity, the widespread adoption of sedentary lifestyles, favorable economic conditions, and rising disposable incomes.

The 3D cardiac mapping system market size is expected to see strong growth in the next few years. It will grow to $2.5 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The anticipated growth during the forecast period is expected to be driven by rapid urbanization, increasing demand for early and accurate diagnosis, heightened awareness among healthcare providers, a growing emphasis on personalized medicine, and the rising need for real-time, high-resolution cardiac mapping. Key trends for this period include the integration of artificial intelligence and machine learning, a focus on patient-centric care, expanded applications in managing complex arrhythmias, advancements in real-time 3D visualization and mapping, and improved catheter designs with higher electrode density.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the 3D cardiac mapping system market. The rise in cardiovascular diseases is influenced by factors such as aging, unhealthy lifestyles, obesity, diabetes, high blood pressure, stress, genetics, environmental pollution, limited access to healthcare, and socioeconomic disparities. A 3D Cardiac Mapping System aids patients with cardiovascular conditions by providing detailed, real-time maps of heart activity, which supports precise diagnosis and treatment of arrhythmias and other heart-related issues. For example, in January 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. These diseases account for around 27% of all deaths in the UK, leading to over 170,000 deaths annually, or about 480 deaths each day. Consequently, the increasing prevalence of cardiovascular diseases is fueling the growth of the 3D cardiac mapping system market.

Leading companies in the 3D cardiac mapping system market are concentrating on developing advanced solutions, such as systems equipped with machine learning capabilities, to enhance diagnostic accuracy and improve treatment outcomes. 3D cardiac mapping systems with machine learning integrate three-dimensional mapping of the heart's electrical activity with artificial intelligence algorithms. For instance, in May 2024, Biosense Webster Inc., a US-based company specializing in cardiac arrhythmia treatment solutions, launched the CARTO 3 System Version 8. This system features machine learning through modules such as the CARTO ELEVATE Module and the CARTOSOUND FAM Module, designed to boost efficiency, consistency, and precision during catheter ablation procedures performed by electrophysiologists. The CARTO 3 system enhances signal analysis, refines substrate characterization, and integrates ultrasound technology for a more effective procedure experience.

In August 2022, Medtronic plc, an Ireland-based medical equipment manufacturer, acquired Affera Inc. for $0.925 billion. This acquisition enables Medtronic to provide a fully integrated diagnostic and therapeutic system for treating various cardiac arrhythmias, including atrial fibrillation. Affera Inc., a US-based medical technology company, offers the Affera Prism-1 cardiac mapping and navigation platform.

Major companies operating in the 3D cardiac mapping system market are Hitachi Ltd., Abbott Laboratories, Siemens Healthineers, Koninklijke Philips N.V, GE HealthCare Technologies Inc, Boston Scientific Corporation, Medtronic PLC, Biotronik Inc, Microport Scientific Inc., Biosense Webster Inc., BioSig Technologies Inc., Heartflow Inc., Stereotaxis Inc., Kardium Inc., Acutus Medical Inc., Volta Medical Inc., Catheter Precision Inc., Osypka Medical Inc., Sichuan Jinjiang Electronic Science and Technology Co Ltd, APN Health LLC, CoreMap Inc.

North America was the largest region in the 3D cardiac mapping system market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 3D cardiac mapping system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the 3D cardiac mapping system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A three-dimensional (3D) cardiac mapping system is a medical device that uses specialized catheters with electrodes inserted into the heart chambers. This system is employed in electrophysiology procedures to generate detailed, three-dimensional maps of the heart's electrical activity.

Key components of 3D cardiac mapping systems include mapping systems, mapping catheters, mapping accessories, and mapping software. Mapping systems create precise spatial representations of cardiac anatomy and electrical activity to aid in the diagnosis and treatment of cardiac arrhythmias. These systems utilize technologies such as electroanatomical mapping, magnetic resonance imaging (MRI) mapping, computed tomography (CT) mapping, and ultrasound mapping. They are used to address conditions such as atrial fibrillation, ventricular tachycardia, atrial flutter, and supraventricular tachycardia. The systems are employed in various settings, including hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and academic and research institutes.

The 3D cardiac mapping system market research report is one of a series of new reports that provides 3D cardiac mapping system market statistics, including 3D cardiac mapping system industry global market size, regional shares, competitors with a 3D cardiac mapping system market share, detailed 3D cardiac mapping system market segments, market trends and opportunities, and any further data you may need to thrive in the 3D cardiac mapping system industry. This 3D cardiac mapping system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D cardiac mapping system market consists of revenues earned by entities by providing services such as arrhythmia detection, ablation guidance, cardiac anatomy visualization, integration with imaging modalities, real-time monitoring, preoperative planning, and postoperative assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D cardiac mapping system market also includes sales of cardiac ablation devices, electrophysiology recording systems, fluoroscopy imaging systems, real-time navigation systems, radiofrequency generators, and cryoablation catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.